ATAD3A promotes bladder cancer progression by regulating glycolysis through MYC stabilization
Open Access
- 18 April 2026
- journal article
- research article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Abstract
Bladder cancer (BCa) remains a major global health challenge with high recurrence and progression rates. Although metabolic reprogramming is recognized asKeywords
Funding Information
- National Natural Science Foundation of China (82472779)
- National Natural Science Foundation of China (82303655)
- Fuling District Science and Technology Research Program (FLKJ.2024AAN3066)
- Fuling District Science and Health Joint Fund (NO.2024KWLH016)
This publication has 38 references indexed in Scilit:
- The structural, functional, and regulatory insight of deubiquitinating enzyme - USP22International Journal of Biological Macromolecules, 2025
- SUMOylation of SETD8 Promotes Tumor Growth by Methylating and Stabilizing MYC in Bladder CancerAdvanced Science, 2025
- Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapyMedical Oncology, 2023
- Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenocarcinomaCancer Letters, 2023
- The deubiquitinase USP10 restores PTEN activity and inhibits non–small cell lung cancer cell proliferationJournal of Biological Chemistry, 2021
- Deubiquitylatinase inhibitor b-AP15 induces c-Myc-Noxa-mediated apoptosis in esophageal squamous cell carcinomaApoptosis, 2019
- Metabolic phenotype of bladder cancerCancer Treatment Reviews, 2016
- Mitochondrial ROS Signaling in Organismal HomeostasisCell, 2015
- Transcriptional Amplification in Tumor Cells with Elevated c-MycCell, 2012
- USP10 Regulates p53 Localization and Stability by Deubiquitinating p53Cell, 2010